Bessemer Group Inc Cytokinetics Inc Transaction History
Bessemer Group Inc
- $61.6 Billion
- Q2 2025
A detailed history of Bessemer Group Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, Bessemer Group Inc holds 517 shares of CYTK stock, worth $30,482. This represents 0.0% of its overall portfolio holdings.
Number of Shares
517
Previous 558
7.35%
Holding current value
$30,482
Previous $23,000
26.09%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CYTK
# of Institutions
375Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.04 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$865 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$707 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$462 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$376 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.55B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...